Literature DB >> 25977524

Registry data highlight increased revision rates for endobutton/biosure HA in ACL reconstruction with hamstring tendon autograft: a nationwide cohort study from the Norwegian Knee Ligament Registry, 2004-2013.

Andreas Persson1, Asle B Kjellsen2, Knut Fjeldsgaard2, Lars Engebretsen3, Birgitte Espehaug4, Jonas M Fevang2.   

Abstract

BACKGROUND: Compared with a patellar tendon autograft (PT), a hamstring tendon autograft (HT) has an increased risk of revision after anterior cruciate ligament reconstruction (ACLR). There are no studies analyzing whether this can be explained by inferior fixation devices used in HT reconstruction or whether the revision risk of ACLR with an HT or a PT is influenced by the graft fixation.
PURPOSE: To compare the risk of revision and the revision rates between the most commonly used combinations of fixation for HTs with PTs. STUDY
DESIGN: Cohort study; Level of evidence, 2.
METHODS: This study included all patients registered in the Norwegian Knee Ligament Registry from 2004 through 2013 who underwent primary PT or HT ACLR with no concomitant ligament injury and known graft fixation. The 2-year revision rates were calculated using the Kaplan-Meier analysis. Hazard ratios (HRs) for revision at 2 years were calculated using multivariate Cox regression models.
RESULTS: A total of 14,034 patients with primary ACLR were identified: 3806 patients with PTs and 10,228 patients with HTs; the mean follow-up time was 4.5 years. In the HT group, 5 different combinations of fixation in the femur/tibia were used in more than 500 patients: Endobutton/RCI screw (n = 2339), EZLoc/WasherLoc (n = 1352), Endobutton/Biosure HA (n = 1209), Endobutton/Intrafix (n = 687), and TransFix II/metal interference screw (MIS) (n = 620). The crude 2-year revision rate for patients with PTs was 0.7% (95% CI, 0.4%-1.0%), and for patients with HTs, it ranged between the groups from 1.5% (95% CI, 0.5%-2.4%) for TransFix II/MIS to 5.5% (95% CI, 4.0%-7.0%) for Endobutton/Biosure HA. When adjusted for detected confounding factors and compared with patients with PTs, the HR for revision at 2 years was increased for all HT combinations used in more than 500 patients, and the combinations Endobutton/Biosure HA and Endobutton/Intrafix had the highest HRs of 7.3 (95% CI, 4.4-12.1) and 5.5 (95% CI, 3.1-9.9), respectively.
CONCLUSION: The choice of fixation after ACLR with an HT has a significant effect on a patient's risk of revision. In this study population, none of the examined combinations of HT fixation had a revision rate as low as that for a PT.
© 2015 The Author(s).

Entities:  

Keywords:  ACL; Endobutton; fixation; reconstruction; revision

Mesh:

Year:  2015        PMID: 25977524     DOI: 10.1177/0363546515584757

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  14 in total

1.  Femoral-tibial fixation affects risk of revision and reoperation after anterior cruciate ligament reconstruction using hamstring autograft.

Authors:  Lindsey M Spragg; Heather A Prentice; Andrew Morris; Tadashi T Funahashi; Gregory B Maletis; Rick P Csintalan
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-03-01       Impact factor: 4.342

2.  ACL reconstruction using 5- or 6-strand hamstring autograft provides graft's diameter bigger than 8 mm.

Authors:  Vytautas Tutkus; Karolis Kluonaitis; Simona Silove; Janina Tutkuviene
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-08-07       Impact factor: 4.342

3.  Anterior laxity and patient-reported outcomes 7 years after ACL reconstruction with a fresh-frozen tibialis allograft.

Authors:  Emily Meike; S M Howell; M L Hull
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-10-20       Impact factor: 4.342

4.  A prospective comparison of 3 hamstring ACL fixation devices-rigidfix, bioscrew, and intrafix-randomized into 4 groups with a minimum follow-up of 5 years.

Authors:  Leena Metso; Ville Bister; Jerker Sandelin; Arsi Harilainen
Journal:  BMC Surg       Date:  2022-06-30       Impact factor: 2.030

5.  Young men are at higher risk of failure after ACL hamstring reconstructions: a retrospective multivariate analysis.

Authors:  Martine C Keuning; Bart J Robben; Reinoud W Brouwer; Martin Stevens; Sjoerd K Bulstra; Rutger G Zuurmond
Journal:  BMC Musculoskelet Disord       Date:  2022-06-21       Impact factor: 2.562

6.  The Role of Lateral Extra-articular Tenodesis in Primary Anterior Cruciate Ligament Reconstruction: A Systematic Review With Meta-analysis and Best-Evidence Synthesis.

Authors:  Brian M Devitt; Stuart W Bell; Clare L Ardern; Taylor Hartwig; Tabitha J Porter; Julian A Feller; Kate E Webster
Journal:  Orthop J Sports Med       Date:  2017-10-24

7.  Cost of Outpatient Arthroscopic Anterior Cruciate Ligament Reconstruction Among Commercially Insured Patients in the United States, 2005-2013.

Authors:  Mackenzie M Herzog; Stephen W Marshall; Jennifer L Lund; Virginia Pate; Jeffrey T Spang
Journal:  Orthop J Sports Med       Date:  2017-01-27

8.  Graft fixation influences revision risk after ACL reconstruction with hamstring tendon autografts.

Authors:  Andreas Persson; Tone Gifstad; Martin Lind; Lars Engebretsen; Knut Fjeldsgaard; Jon Olav Drogset; Magnus Forssblad; Birgitte Espehaug; Asle B Kjellsen; Jonas M Fevang
Journal:  Acta Orthop       Date:  2017-11-24       Impact factor: 3.717

9.  Strength in numbers? The fragility index of studies from the Scandinavian knee ligament registries.

Authors:  Eleonor Svantesson; Eric Hamrin Senorski; Adam Danielsson; David Sundemo; Olof Westin; Olufemi R Ayeni; Kristian Samuelsson
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-06-12       Impact factor: 4.342

10.  Clinical and Functional Outcomes of Anterior Cruciate Ligament Reconstruction at a Minimum of 2 Years Using Adjustable Suspensory Fixation in Both the Femur and Tibia: A Prospective Study.

Authors:  Philippe Colombet; Mo Saffarini; Nicolas Bouguennec
Journal:  Orthop J Sports Med       Date:  2018-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.